Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial

• Main Authors: Xuedong An (Author), Bo Peng (Author), Xiaodong Huang (Author), Hongmei Jiang (Author), Zhang'e Xiong (Author), Hong Zhang (Author), Fengmei Lian (Author), Yuanming Ba (Author), Xiaolin Tong (Author)
• Format: Book
• Published: BMC, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective To explore the effect of Ludangshen oral liquid for treatment of convalescent patients with coronavirus disease 2019 (COVID-19) with randomized, double-blind, placebo-controlled multicenter method. Methods 200 convalescent COVID-19 patients who had symptoms related to decreased di...